PA
TTMI icon

PharVision Advisers’s TTM Technologies TTMI Stock Holding History

PharVision Advisers’s Portfolio TTMI Stock Details TTMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,179
Closed -$288K – 610
2025
Q4 		$288K Sell
4,179
-49
-1% -$3.2K 0.15% 293
2025
Q3 		$244K Buy
+4,228
New +$196K 0.14% 352

Other funds holding TTMI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PharVision Advisers's TTMI Position: Q1 2026 in Review

PharVision Advisers sold out of TTM Technologies (TTMI) in Q1 2026, closing a stake of 4,179 shares — an estimated $288K sold.

PharVision Advisers first reported a position in TTMI in Q3 2025 and held it in 2 quarters. The position peaked at $288K in Q4 2025. 520 funds tracked by Wall St. Rank hold TTMI as of Q1 2026.

  • PharVision Advisers reported no remaining TTM Technologies position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 4,179 TTM Technologies shares in Q1 2026, an estimated $288K.
  • PharVision Advisers first reported a position in TTM Technologies in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's TTM Technologies position peaked at $288K in Q4 2025.
  • 520 funds tracked by Wall St. Rank held TTM Technologies as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.